The role of EVI1 in normal and leukemic cells

Blood Cells, Molecules, and Diseases

Volumn 31, Issue 2, 2003, Pages 206-212

  Buonamici, Silvia ^a   Chakraborty, Soumen ^a   Senyuk, Vitalyi ^a   Nucifora, Giuseppina ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

3q26; AML1 MDS1 EVI1; EVI1; MDS1 EVI1

Indexed keywords

TRANSCRIPTION FACTOR; CYTOKINE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECOTROPIC VIRUS; ERYTHROID CELL; FUSION GENE; GENE; GENE EVI1; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE TRANSLOCATION; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; MEGAKARYOCYTE; MOUSE; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STEM CELL; VIRUS DNA CELL DNA INTERACTION; BONE MARROW TUMOR; ECOTROPIC VIRAL INTEGRATION 1 SITE GENE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; RETROVIRUS;

MURINAE;

EID: 0348014495     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00159-1     Document Type: Article

References (51)

1. Nucifora G. The EVI1 gene in myeloid leukemia. Leukemia. 11:1999;2002-2031.
2. Jolkowska J., Witt M. The EVI-1 gene-its role in pathogenensis of human leukemias. Leuk. Res. 24:2000;553-558.
3. Mucenski M.L., Taylor B.A., Copeland N.G., Jenkins N.A. Chromosomal location of EVI1 in the DNA of AKXD murine myeloid tumors. Oncol. Res. 2:1998;219-233.
4. Moroshita K., Parganas E., Douglass E.C., Ihle J.N. The unique expression of human EVI1 gene in endometrial calcinoma cell line sequence of cDNA and structure of alternatively spliced transcripts . Oncogene. 5:1990;963-971.
5. Suzukawa K., Taki T., Abe T., Asoh H., Kamada N., Yokota J., Moroshita K. Identification of translocational breakpoint within the intron region before the last coding exon (exon 12) of the EVI-1 gene in two cases of CML-BC with inv(3)(q21q26). Genomics. 42:1997;356-360.
6. Delwel R., Funabiki T., Kreider B.L., Morishita K., Ihle J.N. Four of the seven zinc finger of the EVI1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA. Mol. Cell Biol. 13:1993;4291-4300.
7. Funabiki T., Kreider B.L., Morishita K., Ihle J.N. The carboxyl domain of the zinc finger of EVI1 myeloid transforming gene binds a consensus sequence GAAGATGAG. Oncogene. 5:1994;1575-1581.
8. Bordereaux D., Fischelson S., Tambourin P., Gisselbrecht S. Alternative splicing of EVI1 zinc finger gene generates mRNA which differ by number of zinc finger motifs. Oncogene. 5:1990;925-927.
9. Perkins A.S., Mercer J.A., Jenkins N.A., Copeland N.G. Patterns of EVI1 expression in embryonic and adult tissues suggest that EVI1 plays an important regulatory role in mouse development. Development. 111:1991;479-487.
10. Hoyt P.R., Bartholomew C., Davis A.J., Yutzey K., Garner L.W., Potter S.S., Ihle J.N., Mucenski M.L. The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech. Dev. 65:1997;55-70.
11. Moroshita K., Parganas E., Parham D.M., Matsugi T., Ihle J.N. The EVI1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. Oncogene. 5:1990;1419-1423.
12. Lopingco M.C., Perkins A.S. Molecular analysis of EVI1 a zinc finger oncogene involved in myeloid leukemia. Cur. Top. Microbiol. Immunol. 211:1996;211-222.
13. Fears S., Mathieu C., Zeleznik-Le N., Huang S., Rowley J.D., Nucifora G. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR family. Proc. Natl. Acad. Sci. USA. 93:1996;1642-1647.
14. Liu L., Shao G., Steele-Perkins G., Huang S. The retinoblastoma interecting zinc finger gene RIZ produces a PR domain lacking product through an internal promoter. J. Bio. Chem. 272:1997;2984-2991.
15. Lin Y., Wong K.K., Calame K. Repression of c-myc transcription by Blimp1, an inducer of terminal B-cell differentiation. Science. 276:1997;596-599.
16. Garringa G., Guenther C., Horvitz H.R. Migration of the Canenorhabditis elegans HSNs are regulated by egl-43, a gene encoding two zinc finger proteins. Genes Devel. 7:1993;2097-2109.
17. Jiang G.L., Huang S. The yin-yang of PR-domain family genes in tumorigenesis. Histol. Histopathol. 15:2000;109-117.
18. Schaeper U., Boyd J.M., Verma S., Uhlmann E., Subramanian T., Chinnadurai G. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc. Natl. Acad. Sci. USA. 92:1995;10467-10471.
19. Postigo A.A., Dean D.C. Independent repressor domains in ZEB regulate muscle and T-cell differentiation. Mol. Cell Biol. 19:1999;961-971.
20. Turner J., Crossley M. Cloning and characterization of mCtBP2, a corepressor that associates with basic Kruppel-like factor and other mammalian transcriptional regulators. EMBO J. 17:1998;5129-5140.
21. Holmes M., Turner J., Fox A., Chishol O., Crossley M., Chong B.J. hFOG-2, a novel zinc finger protein, binds the co-repressor mCtBP2 and modulates GATA-mediated activation. J. Biol. Chem. 274:1999;23491-23498.
22. Criqui-Filipe P., Ducret C., Maira S.M., Wasylyk B. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. EMBO J. 18:1999;3392-3403.
23. Meloni A.R., Smith E.J., Nevins J.R. A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor. Proc. Natl. Acad. Sci. USA. 96:1999;9574-9579.
24. Yu X., Wu L.C., Bowcock A.M., Aronheim A., Baer R. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273:1998;25388-25392.
25. Izutsu K., Kurokawa M., Imai Y., Maki Y., Mitani K., Hirai H. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. Blood. 97:2001;2815-2822.
26. Chakraborty S., Senyuk V., Sitailo S., Chi Y., Nucifora G. Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles. J. Biol. Chem. 276:2001;44936-44943.
27. Palmer S., Brouillet J.P., Kilbey A., Fulton R., Walker M., Crossley M., Bartholomew C. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. J. Biol. Chem. 276:2001;25834-25840.
28. Kurokawa M., Mitani K., Irie K., Matsuyama T., Takahashi T., Chiba S., Yazaki Y., Matsumoto K., Hirai H. The oncoprotein Evi-1 represses TGF-beta signaling by inhibiting Smad3. Nature. 394:1998;92-96.
29. Sood R., TalwarTrikha A., Chakrabarti S.R., Nucifora G. MDS1-EVI1 enhances TGF-β1 signaling and strengthens its growth-inhibitory effect, but the leukemia-associated fusion protein AML1-MDS1-EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-β1. Leukemia. 13:1999;348-357.
30. Sitailo S., Sood R., Barton K., Nucifora G. Forced expression of the leukemia-associated gene EVI1 in ES cells model for myeloid leukemia with 3q26 rearrangements . Leukemia. 13:1999;1639-1645.
31. Vinatzer U., Taplick J., Seiser C., Fonatsch C., Wieser R. The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase. Br. J. Haematol. 114:2001;566-573.
32. Kurokawa M., Mitani K., Yamagata T., Takahashi T., Izutsu K., Ogawa S., Moriguchi T., Nishida E., Yazaki Y., Hirai H. The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death. EMBO J. 19:2000;2958-2968.
33. Fishelson S., Dreyfus F., Berger R., Melle J., Bastard C., Miclea J., Gisselbrecht S. EVI1 expression in leukemic patients with rearrangements of the 3q25-28 chromosomal region. Leukemia. 6:1992;93-99.
34. Suzukawa K., Parganas E., Gajjar A., Abe T., Tarkahashi S., Tani K., Asano S., Asou H., Kamada N., Moroshita K., Ihle J.N. Identification of breakpoint cluster region 3′ of Ribophorin I gene at 3q21 associated with the transcriptional activation of EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood. 84:1994;2681-2688.
35. Testoni N., Borsaru G., Martinelli G., Carboni C., Ruggeri D., Ottaviani E., Pelliconi S., Ricci P., Pastano R., Visani G., Zaccaria A., Tura S. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia biological and clinical features . Haematologica. 84:1999;690-694.
36. Barjesteh van Waalwjik van Doorn-Khosrovani S., Erpelinck C., van Putten W.L., Valk P.J., van der Poel-van de Luytgaarde S., Hack R., Slater R., Smit E.M., Beverloo H.B., Verhoef G., Verdonck L.F., Ossenkoppele G.J., Sonneveld P., de Greef G.E., Lowenberg B., Delwel R. High EVI1 expression predicts poor survival in acute myeloid leukemia a study of 319 de novo AML patients . Blood. 101:2003;837-845.
37. Ogawa S., Kurokawa M., Tanaka T., Tanaka K., Hangaishi A., Mitani K., Kamada N., Yazaki Y., Hirai H. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. Leukemia. 10:1996;788-794.
38. Johansson B., Fioretos T., Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol. 107:2002;76-94.
39. Moroshita K., Parganas E., Matsugi T., Ihle J.N. Expression of the EVI1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol. Cell Biol. 12:1992;183-189.
40. Kreider B.L., Orkin S.H., Ihle N.J. Loss of erythropoietin responsiveness in erythroid progenitors due to the expression of the EVI1 myeloid-transforming gene. Proc. Natl. Acad. Sci. USA. 90:1993;6454-6458.
41. Rubin C.M., Larson R.A., Anastasi J., Winter J.N., Thangavelu M., Vardiman J.W., Rowley J.D., Le Beau M.M. t(3;21)(q26;q22) a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia . Blood. 76:1990;2594-2598.
42. Nucifora G., Birn D.J., Espinosa R. 3rd, Erickson P., LeBeau M.M., Roulston D., McKeithan T.W., Drabkin H., Rowley J.D. Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood. 81:1993;2728-2734.
43. Nucifora G., Begy K.R., Kobayashi H., Roulston D., Claxton D., Pedersen-Bjergaard J., Parganas E., Ihle J.N., Rowley J.D. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc. Natl. Acad. Sci. USA. 91:1994;4004-4008.
44. Senyuk V., Chakraborty S., Mikhail F., Zhao R., Chi Y., Nucifora G. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells. Oncogene. 21:2002;3232-3240.
45. Ogawa E., Maruyama M., Kagoshima H., Inuzuka M., Lu J., Satake M., Shigesada K., Ito Y. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA. 90:1993;6859-6863.
46. Zent C., Kim N., Hiebert S., Zhang D.E., Tenen D.G., Rowley J.D., Nucifora G. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties . Curr. Top. Microbiol. Immunol. 211:1996;243-252.
47. Zhang D.E., Hetherington C.J., Meyers S., Rhoades K., Larson C.J., Chen H.M., Hiebert S.W., Tenen D.G. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell Biol. 16:1996;1231-1240.
48. Soderholm J., Kobayashi H., Mathieu C., Rowley J.D., Nucifora G. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. Leukemia. 11:1997;352-358.
49. Kurokawa M., Ogawa S., Tanaka T., Mitani K., Yazaki Y., Witte O.N., Hirai H. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence. Oncogene. 11:1995;833-840.
50. Cuenco G.M., Nucifora G., Ren R. Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice a model for human AML . Proc. Natl. Acad. Sci. USA. 97:2000;1760-1765.
51. Cuenco G.M., Ren R. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia. Oncogene. 20:2001;8236-8248.